Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Andrews

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Nature Immunology|January 22, 2008
Stress gets under your skinDaniel M Andrews, Mark J Smyth
Immunology and Cell Biology|December 2, 2009
A potential role for RAG-1 in NK cell development revealed by analysis of NK cells during ontogenyDaniel M Andrews, Mark J Smyth
Immunological Reviews|March 28, 2008
Cancer vaccines for established cancer: how to make them better?Daniel M Andrews, Eugene Maraskovsky, Mark J Smyth
Methods in Molecular Biology (Clifton, N.J.)|December 25, 2009
Subset analysis of human and mouse mature NK cellsYoshihiro Hayakawa, Daniel M Andrews, Mark J Smyth
European Journal of Immunology|November 4, 2008
Can NK cells be a therapeutic target in human cancer?Christopher J Chan, Daniel M Andrews, Mark J Smyth
Current Opinion in Immunology|January 31, 2012
Receptors that interact with nectin and nectin-like proteins in the immunosurveillance and immunotherapy of cancerChristopher J Chan, Daniel M Andrews, Mark J Smyth
Immunological Reviews|November 15, 2006
Natural killer cells in viral infection: more than just killersChristopher E Andoniou, Daniel M Andrews, Mariapia A Degli-Esposti
Molecular Immunology|May 24, 2018
The expanding role of murine class Ib MHC in the development and activation of Natural Killer cellsKatharine J Goodall, Angela Nguyen, Lucy C Sullivan, et al.
Oncoimmunology|June 27, 2013
Non-classical MHC Class I molecules regulating natural killer cell functionMark J Smyth, Lucy C Sullivan, Andrew G Brooks, et al.
Trends in Immunology|March 30, 2002
IL-2 mediates adjuvant effect of dendritic cellsFrancesca Granucci, Daniel M Andrews, Mariapia A Degli-Esposti, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Nature Immunology|January 22, 2008
Stress gets under your skinDaniel M Andrews, Mark J Smyth
Immunology and Cell Biology|December 2, 2009
A potential role for RAG-1 in NK cell development revealed by analysis of NK cells during ontogenyDaniel M Andrews, Mark J Smyth
Immunological Reviews|March 28, 2008
Cancer vaccines for established cancer: how to make them better?Daniel M Andrews, Eugene Maraskovsky, Mark J Smyth
Methods in Molecular Biology (Clifton, N.J.)|December 25, 2009
Subset analysis of human and mouse mature NK cellsYoshihiro Hayakawa, Daniel M Andrews, Mark J Smyth
European Journal of Immunology|November 4, 2008
Can NK cells be a therapeutic target in human cancer?Christopher J Chan, Daniel M Andrews, Mark J Smyth
Current Opinion in Immunology|January 31, 2012
Receptors that interact with nectin and nectin-like proteins in the immunosurveillance and immunotherapy of cancerChristopher J Chan, Daniel M Andrews, Mark J Smyth
Immunological Reviews|November 15, 2006
Natural killer cells in viral infection: more than just killersChristopher E Andoniou, Daniel M Andrews, Mariapia A Degli-Esposti
Molecular Immunology|May 24, 2018
The expanding role of murine class Ib MHC in the development and activation of Natural Killer cellsKatharine J Goodall, Angela Nguyen, Lucy C Sullivan, et al.
Oncoimmunology|June 27, 2013
Non-classical MHC Class I molecules regulating natural killer cell functionMark J Smyth, Lucy C Sullivan, Andrew G Brooks, et al.
Trends in Immunology|March 30, 2002
IL-2 mediates adjuvant effect of dendritic cellsFrancesca Granucci, Daniel M Andrews, Mariapia A Degli-Esposti, et al.
Pageof 7